|
de Araujo FM, Cuenca-Bermejo L, Fernandez-Villalba E, Costa SL, Silva VDA, Herrero MT. Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy. Cell Mol Neurobiol. 2022 Jul;42(5):1283-1300. doi: 10.1007/s10571-020-01027-6. Epub 2021 Jan 2. PubMed PMID: 33387119.
AÑO: 2022; IF: 4.0
|
33387119
|
Cuenca-Bermejo L, Almela P, Gallo-Soljancic P, Yuste JE, de Pablos V, Bautista-Hernandez V, Fernandez-Villalba E, Laorden ML, Herrero MT. Cardiac tyrosine hydroxylase activation and MB-COMT in dyskinetic monkeys. Sci Rep. 2021 Oct 6;11(1):19871. doi: 10.1038/s41598-021-99237-5. PubMed PMID: 34615910; PubMed Central PMCID: PMC8494805.
AÑO: 2021; IF: 4.996
|
|
Fuentes P, Amador S, Lucas-Ochoa AM, Cuenca-Bermejo L, Fernandez-Villalba E, Raparelli V, Norris C, Kautzky-Willer A, Kublickiene K, Pilote L, Herrero MT; GOING-FWD Consortium. Sex, rurality and socioeconomical status in Spanish centennial population (2017). Aging (Albany NY). 2021 Sep 26;13(18):22059-22077. doi: 10.18632/aging.203563. Epub 2021 Sep 26. PubMed PMID: 34565717; PubMed Central PMCID: PMC8507300.
AÑO: 2021; IF: 5.955
|
|
Cuenca-Bermejo L, Pizzichini E, Goncalves VC, Guillen-Diaz M, Aguilar-Monino E, Sanchez-Rodrigo C, Gonzalez-Cuello AM, Fernandez-Villalba E, Herrero MT. A New Tool to Study Parkinsonism in the Context of Aging: MPTP Intoxication in a Natural Model of Multimorbidity. Int J Mol Sci. 2021 Apr 21;22(9):4341. doi: 10.3390/ijms22094341. PubMed PMID: 33919373; PubMed Central PMCID: PMC8122583.
AÑO: 2021; IF: 6.208
|
|
Costa T, Fernandez-Villalba E, Izura V, Lucas-Ochoa AM, Menezes-Filho NJ, Santana RC, de Oliveira MD, Araujo FM, Estrada C, Silva V, Costa SL, Herrero MT. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice. J Neuroimmune Pharmacol. 2021 Jun;16(2):390-402. doi: 10.1007/s11481-020-09925-8. Epub 2020 Jun 21. PubMed PMID: 32564332.
AÑO: 2021; IF: 7.285
|